Search

Search Constraints

You searched for: Author/Creator Worden, Francis

Search Results

1. 354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer. (9th November 2020)

2. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020)

3. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020)

4. ACR Appropriateness Criteria® Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Issue 2 (21st January 2016)

6. ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Issue 9 (22nd June 2016)

7. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Issue 3 (29th December 2016)

8. American college of radiology appropriateness criteria® treatment of stage I T1 glottic cancer. Issue 1 (18th September 2013)

9. Aspiration pneumonia after chemo–intensity‐modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia‐related predictors. Issue 1 (1st June 2013)

10. Biomarkers in advanced larynx cancer. (12th July 2013)